MISSION VIEJO, Calif., Dec. 27, 2017 -- The Ensign Group, Inc. (Nasdaq:ENSG), the parent company of the Ensign™ group of skilled nursing, rehabilitative care services, home health care, hospice care and assisted living companies, today announced that certain of its subsidiaries recently completed a $112 million portfolio financing with low, fixed-rate loans amortized over 30- or 35-year terms and secured by mortgages on seventeen of the sixty-three properties owned by Ensign subsidiaries.
The borrowings were arranged by Lancaster Pollard Mortgage Company, LLC, and insured by the Department of Housing and Urban Development (HUD). Loan proceeds will be primarily deployed to pay down previously drawn amounts on Ensign's revolving line of credit.
"These new long-term, fixed-rate borrowings represent an important pillar in our capital structure, providing us liquidity on a portion of the real estate we own during a period of historically-low interest rates," said Suzanne Snapper, Ensign's Chief Financial Officer. "We appreciate the collaboration of our lending partners and look forward to exploring additional opportunities to leverage the significant upside in the remainder of our owned-asset portfolio," she added.
Ms. Snapper confirmed that in addition to refinancing existing borrowings, the proceeds of the HUD-insured debt will be used to fund acquisitions, to renovate and upgrade existing and future facilities, to cover working capital needs and for other business purposes.
About Ensign™
The Ensign Group, Inc.'s independent operating subsidiaries provide a broad spectrum of skilled nursing and assisted living services, physical, occupational and speech therapies, home health and hospice services and other rehabilitative and healthcare services at 230 healthcare facilities, twenty-two hospice agencies, twenty home health agencies and four home care businesses in California, Arizona, Texas, Washington, Utah, Idaho, Colorado, Nevada, Iowa, Nebraska, Oregon, Wisconsin, Kansas, South Carolina, and Oklahoma. More information about Ensign is available at http://www.ensigngroup.net.
Contact Information
The Ensign Group, Inc., (949) 487-9500, [email protected]
SOURCE: The Ensign Group, Inc.


Petrobras Posts Record Oil Exports as Production Surge Fuels Global Expansion
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes
Instagram CEO Defends Platform in Youth Mental Health Lawsuit Over Social Media Addiction Claims
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide
AST SpaceMobile Joins MSCI ACWI Index as Largest New Addition, Boosting Market Visibility
Cloudflare Forecasts Strong Revenue Growth as AI Fuels Cloud Services Demand
More U.S. Investors Join Arbitration Against South Korea Over Coupang Dispute
U.S. Judge Allows Jeffrey Epstein Sex Trafficking Lawsuit Against Bank of America to Proceed
xAI Co-Founder Jimmy Ba Departs as Elon Musk’s AI Startup Faces Turbulence
AbbVie Sues HHS Over Medicare Price Controls on Botox Under Inflation Reduction Act
How Marco Pharma International Preserves German Homeopathic Traditions in America
Ralph Lauren Unveils Elegant Fall 2026 Women’s Collection Ahead of New York Fashion Week
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks
Samsung Electronics Sees Sustained AI-Driven Demand for Memory Chips Into Next Year 



